Status:
WITHDRAWN
Steroids for Rhinoplasty: Pain, Nausea, Edema and Ecchymosis
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Edema
Bruising
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will be a prospective randomized study to evaluate the effect of medrol dosepaks (oral corticosteroids) on postoperative outcomes among patients undergoing rhinoplasty by Facial Plastic Sur...
Detailed Description
This study will be a prospective randomized study to evaluate the effect of medrol dosepaks (oral corticosteroids) on postoperative outcomes among patients undergoing rhinoplasty by Facial Plastic Sur...
Eligibility Criteria
Inclusion
- Adults at least 18 years of age who elect to undergo cosmetic or functional open primary rhinoplasty with/without osteotomies (repositioning the nasal bones)
- No other facial plastics procedure nor sinus surgery performed simultaneously.
Exclusion
- revision rhinoplasty
- diabetic patients
- patients with an allergy to steroids
- use of PPE implants
- parents receiving concurrent sinus surgery
- patients receiving biologics or preop oral steroids
- Patients that are pregnant or attempting to conceive
- Liver failure or cirrhosis
- Diagnosis of hypothyroidism
- Diagnosis of glaucoma
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06483204
Start Date
January 1 2026
End Date
January 1 2027
Last Update
November 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.